Our Programs are:
The Advanced Human Imaging Program equips and operates Australia’s most advanced human imaging capabilities, instruments and expertise. It is critical to understanding how the brain functions, studying disease states, understanding how we age, and developing new pharmaceuticals and medical devices.
Advanced Human Imaging underpins work that is of high priority to reduce Australia’s burden of disease such as large-scale studies of dementias, epilepsy, multiple sclerosis, stroke, liver and kidney diseases, mental health and cognition.
Preclinical and Frontier Imaging provides infrastructure for advanced imaging of preclinical models, plants and specimens, materials and minerals – all supported by specialised expertise.
The Program plays a vital role in advancing Australia’s medical, manufacturing and environment industries, and is used to digitise unique national-priority collections.
Radiopharmaceuticals are a vital nuclear medicine product used for visualising biological processes in medical research through molecular imaging. NIF supports the development of new radiotracers, enables open access to cyclotrons, and coordinates the supply of cyclotron-produced radioisotopes for research and industry.
Radiopharmaceuticals are critical for medical diagnosis and therapy; the ability to produce radiopharmaceuticals in Australia is an important sovereign capability with significant potential for commercial innovation.
Data Collections and Partnerships is a new NIF Program which will help create imaging data collections of national priority, and deploy the digital infrastructure and expertise required to translate them into valuable information.
NIF will work in partnership to create, establish and manage imaging data assets underpinning the next generation of medical research in critical fields – including imaging-based precision medicine studies – and help translate the application of imaging AI solutions into health care and products.